The purpose of this study is to evaluate the safety and effectiveness of an investigational vaccine for cytomegalovirus (CMV) in adults ages 18 to 40.
Duration: Approximately 18 months
Number of visits to AMR Lexington: 12, plus 6 telephone calls
Qualifications: Qualified participants must be between the ages of 18 and 40 years old and be in general good health. Other criteria also apply.
CMV Vaccine Study